Relapse Surveillance
Relapse Surveillance is a clinical monitoring framework designed to systematically detect the re-emergence of disease activity in patients with a history of remission, specifically distinguishing itself by its focus on early identification of recurrent intraocular lymphoma through regular ophthalmologic, imaging, and laboratory assessments.
133
Publications
7.6K
Citations
1.1K
Authors
475
Institutions
Publications per year
2017–2026
37
133
1–5 of 133
1.1K
5
h-index
5
h-index
4
h-index
4
h-index
4
h-index
1–5 of 1.1K
475
Heidelberg University
Heidelberg, Germany
9 h-index
13 publications
883 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
9 h-index
51 publications
3K citations
Dana-Farber Cancer Institute
Boston, United States
6 h-index
16 publications
931 citations
Université Claude Bernard Lyon 1
Villeurbanne, France
6 h-index
46 publications
4.6K citations
University of Pennsylvania
Philadelphia, United States
6 h-index
9 publications
406 citations
Hospices Civils de Lyon
Lyon, France
5 h-index
11 publications
862 citations
Ludwig-Maximilians-Universität München
Munich, Germany
5 h-index
5 publications
735 citations

Princess Margaret Cancer Centre
Toronto, Canada
5 h-index
34 publications
1.5K citations
1–8 of 475
11 publications · 1.6K citations
11
h-index
10 publications · 1.1K citations
10
h-index
9 publications · 405 citations
9
h-index
5 publications · 197 citations
5
h-index
5 publications · 163 citations
5
h-index
1–5